SavedAdd your journal

Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 3

The Pathophysiology of Vitreomacular Interface Disease

Vitreomakuler Ara Yüzey Hastalıklarının Patofizyolojisi

Hakkı BİRİNCİ
Volkan YETER
Pages
224–230
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Having a clear understanding of the pathophysiology of these diseases may help to develop new pharmacologic or surgical treatment modalities..

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anomalous posterior vitreous detachment is an important step in the pathogenesis of vitreoretinal interface diseases.
📊
Key Findings & Data:In order to understand the pathophysiology of vitreoretinal interface diseases, the structure and biochemistry of the vitreous body, and its relation with the retina should be investigated.
💡
Conclusion & Impact:Having a clear understanding of the pathophysiology of these diseases may help to develop new pharmacologic or surgical treatment modalities..
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Anomalous posterior vitreous detachment is an important step in the pathogenesis of vitreoretinal interface diseases. In order to understand the pathophysiology of vitreoretinal interface diseases, the structure and biochemistry of the vitreous body, and its relation with the retina should be investigated. Having a clear understanding of the pathophysiology of these diseases may help to develop new pharmacologic or surgical treatment modalities..

Özet

Anormal posterior vitreus dekolmanı, vitreoretinal arayüzey hastalıklarının patogenezinde önemli bir basamaktır. Vitreoretinal arayüzey hastalıklarının patofizyolojisini anlayabilmek için; vitreusun yapısı, biyokimyası ve onun retina ile olan ilişkisi incelenmelidir. Bu hastalıkların patofizyolojisinin net bir şekilde anlaşılması, yeni farmakolojik veya cerrahi tedavilerin geliştirilmesine yardımcı olabilir.

🔖

Cite This Article

BİRİNCİ, H., YETER, V. (2018). The Pathophysiology of Vitreomacular Interface Disease. Güncel Retina Dergisi, Cilt: 2 - Sayı: 3, 224–230. https://ajindex.com/articles/173576

References (9)

  1. de Smet MD, Gad Elkareem AM, Zwinderman AH. The vitreous, the retinal interface in ocular health and disease. Ophthalmologica. 2013; 230(4):165- 178. Snowden JM. The stabilization of in vivo assembled collagen fibrils by proteoglycans/glycosaminoglycans. Biochim Biophys Acta. 1982;703(1):21-25.
  2. Schmut O, Mallinger R, Paschke E. Studies on a distinct fraction of bovine vitreous body collagen. Graefes Arch Clin Exp Ophthalmol 1984;221(6):286- 289. Maumenee IH. Vitreoretinal degeneration as a sign of generalized connective tissue diseases. Am J Ophthalmol. 1979;88(3 Pt 1):432-449.
  3. Bishop PN, Crossman MV, McLeod D, Ayad S. Extraction and characterization of the tissue forms of collagen types II and IX from bovine vitreous. Biochem J. 1994;299 ( Pt 2):497-505.
  4. Bishop PN, Reardon AJ, McLeod D, Ayad S. Identification of alternatively spliced variants of type II procollagen in vitreous. Biochem Biophys Res Commun. 1994;203(1):289-295. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res. 2000;19(3):323-344.
  5. Reardon AJ, Le Goff M, Briggs MD, McLeod D, Sheehan JK, Thornton DJ, et al. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem. 2000;275(3):2123-2129.
  6. Sanders EJ, Walter MA, Parker E, Aramburo C, Harvey S. Opticin binds retinal growth hormone in the embryonic vitreous. Invest Ophthalmol Vis Sci. 2003;44(12):5404-5409.
  7. Hindson VJ, Gallagher JT, Halfter W, Bishop PN. Opticin binds to heparan and chondroitin sulfate proteoglycans. Invest Ophthalmol Vis Sci. 2005;46(12):4417-4423.
  8. Monfort J, Tardif G, Roughley P, Reboul P, Boileau C, Bishop PN, et al. Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis. Osteoarthritis Cartilage. 2008;16(7):749-755.
  9. Cain SA, Morgan A, Sherratt MJ, Ball SG, Shuttleworth CA, Kielty CM. Proteomic analysis of fibrillin-rich microfibrils. Proteomics. 2006;6(1):111- 122. Osterlin SE, Jacobson B. The synthesis of hyaluronic acid in vitreous. I. Soluble and particulate transferases in hyalocytes. Exp Eye Res. 1968;7(4):497- 510. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev. 1978;58(1):255-315. Sebag J. Diabetic vitreopathy. Ophthalmology. 1996;103(2):205-206. Cohen AI. Electron microscopic observations of the internal